Intellia Therapeutics
NTLA
NTLA
283 hedge funds and large institutions have $1.92B invested in Intellia Therapeutics in 2024 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 113 increasing their positions, 86 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
11% less first-time investments, than exits
New positions opened: 42 | Existing positions closed: 47
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
48% less call options, than puts
Call options by funds: $10.9M | Put options by funds: $20.9M
Holders
283
Holding in Top 10
3
Calls
$10.9M
Puts
$20.9M
Top Buyers
| 1 | +$18M | |
| 2 | +$15.2M | |
| 3 | +$15M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.2M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$11.1M |
Top Sellers
| 1 | -$25.5M | |
| 2 | -$15.3M | |
| 3 | -$11.5M | |
| 4 |
PA
Pinnacle Associates
New York
|
-$5.62M |
| 5 |
Aberdeen Group
Edinburgh,
United Kingdom
|
-$5.44M |